LAI FENG Co., Ltd.: Q1 2026 EPS of 1.41 NTD

Key facts

  • LAI FENG Co., Ltd.: Q1 2026 EPS of 1.41 NTD
  • LAI FENG Co., Ltd. announced its Q1 2026 financial results, reporting revenue of NTD 918 million, net income after tax of NTD 116 million, and basic earnings per share (EPS) of NTD 1.41. The company operates in the biotechnology and medical industry.
  • Source: PR Times
  • Date: March 1, 2026

Direct answer

LAI FENG Co., Ltd. announced its Q1 2026 financial results, reporting revenue of NTD 918 million, net income after tax of NTD 116 million, and basic earnings per share (EPS) of NTD 1.41. The company operates in the biotechnology and medical industry.

Citation
LAI FENG Co., Ltd.: Q1 2026 EPS of 1.41 NTD (March 1, 2026), PR Times
Source
PR Times
Date
March 1, 2026
LAI FENG Co., Ltd. announced its Q1 2026 financial results, reporting revenue of NTD 918 million, net income after tax of NTD 116 million, and basic earnings per share (EPS) of NTD 1.41. The company operates in the biotechnology and medical industry.
その他NQ 0/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: March 1, 2026 at 09:00
  • 🔍 Collected: May 14, 2026 at 08:00 (1775h 0m after Published)
  • 🤖 AI Analyzed: May 14, 2026 at 08:11 (10 min after Collected)
Company Code: 4137
Company Name: LAI FENG Co., Ltd.
Industry: Biotechnology and Medical Industry
Fiscal Year/Quarter: Q1 2026
Basic Earnings Per Share: 1.41 NTD
Operating Revenue: 918 million NTD
Net Income After Tax: 116 million NTD

FAQ

What are the key facts in this article?

LAI FENG Co., Ltd. announced its Q1 2026 financial results, reporting revenue of NTD 918 million, net income after tax of NTD 116 million, and basic earnings per share (EPS) of NTD 1.41. The company operates in the biotechnology and medical industry.

What is the direct answer?

LAI FENG Co., Ltd. announced its Q1 2026 financial results, reporting revenue of NTD 918 million, net income after tax of NTD 116 million, and basic earnings per share (EPS) of NTD 1.41. The company operates in the biotechnology and medical industry.

What is the source and date?

PR Times: https://openapi.twse.com.tw/financial/twse-fin-4137-2026Q1 | March 1, 2026